John Marshall, MD is the Director of Oncology Services for Georgetown University Hospital, Associate Director of Clinical Research of the Lombardi Comprehensive Cancer Center, and Chief of the Division of Hematology-Oncology.
Dr. Marshall is an internationally recognized expert in new drug development for GI cancer, with expertise in phase I, II, and III trial design, and has served as Principal Investigator for more than one hundred clinical trials. While he has an interest in many areas of cancer research, his primary focus has been on the development of vaccines to treat cancer.
In 2008, he established the Otto J Ruesch Center for the Cure of GI Cancers, an organization solely focused on improving the lives of GI cancer patients through innovative research, personalized medicine, and focused advocacy.
He is widely published in the field of clinical oncology, reviews manuscripts for eight journals, including Journal of Clinical Oncology, Clinical Cancer Research and Investigational New Drugs. He also holds peer-reviewed grants from the National Institutes of Health.
Dr. Marshall is a member of several societies including ASCO, has participated in numerous advisory boards, and consulted for pharmaceutical companies.